I'm LongbridgeAI, I can summarize articles.The Week
GUSHENGTANG fell 2.42% this week, closing at HK$29.02. The Hang Seng Index lost 3.32%, so the stock outperformed the benchmark by about 0.9 percentage points. Trading was choppy: Monday opened higher at HK$29.84 before slipping, Tuesday recovered to HK$29.50, Wednesday dipped to HK$28.84, and Thursday settled near HK$29.02. No major catalyst emerged this week, though average daily volume of 577.4k shares was slightly above its recent median.
Analyst Ratings
Of 19 brokers covering the stock, 15 rate it buy, 3 rate it outperform, and 1 rates it sell; none rate it hold. The consensus rating is strong buy, with a consensus target of HK$40.14, about 38.3% above the latest close. Targets range from HK$25.26 to HK$60.08, reflecting wide dispersion. The stock ranks first among 8 names in the healthcare services industry.
The Week Ahead
Hong Kong unemployment data lands on 17 November, with a prior reading of 3.9%; CPI follows on 20 November, previously 1.9%. For the company itself, the next key date is 27 November, when third-quarter fiscal 2026 results are due. Full-year results are scheduled for 30 March 2027.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
